Invesco Ltd. Adma Biologics, Inc. Transaction History

Invesco Ltd.

$503 Billion
Q1 2025

A detailed history of Invesco Ltd. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 12,866,904 shares of ADMA stock, worth $235 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

12,866,904

Previous 11,296,255 13.9%

Holding current value

$235 Million

Previous $194 Million 31.77%

% of portfolio

0.05%

Previous 0.04%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$15.44 - $20.61 $24.3 Million - $32.4 Million	1,570,649 Added 13.9%	12,866,904 $255 Million
Q4 2024 Feb 13, 2025	SELL	$15.62 - $22.62 $20.7 Million - $29.9 Million	-1,323,514 Reduced 10.49%	11,296,255 $194 Million
Q3 2024 Nov 12, 2024	SELL	$11.21 - $20.03 $6.18 Million - $11 Million	-550,967 Reduced 4.18%	12,619,769 $252 Million
Q2 2024 Aug 13, 2024	BUY	$5.98 - $11.18 $32.1 Million - $60 Million	5,366,509 Added 68.76%	13,170,736 $147 Million
Q1 2024 May 14, 2024	BUY	$4.4 - $6.74 $7.45 Million - $11.4 Million	1,692,454 Added 27.69%	7,804,227 $51.5 Million
Q4 2023 Feb 12, 2024	BUY	$3.08 - $4.52 $2.14 Million - $3.14 Million	694,607 Added 12.82%	6,111,773 $27.6 Million
Q3 2023 Nov 13, 2023	BUY	$3.47 - $4.61 $1.48 Million - $1.97 Million	426,446 Added 8.54%	5,417,166 $19.4 Million
Q2 2023 Aug 11, 2023	BUY	$3.12 - $4.22 $512,004 - $692,518	164,104 Added 3.4%	4,990,720 $18.4 Million
Q1 2023 May 12, 2023	BUY	$3.01 - $3.87 $1.85 Million - $2.38 Million	615,141 Added 14.61%	4,826,616 $16 Million
Q4 2022 Feb 13, 2023	BUY	$2.47 - $3.88 $1.94 Million - $3.05 Million	785,726 Added 22.94%	4,211,475 $16.3 Million
Q3 2022 Nov 14, 2022	BUY	$2.03 - $2.86 $6.31 Million - $8.89 Million	3,109,896 Added 984.6%	3,425,749 $8.33 Million
Q2 2022 Aug 15, 2022	SELL	$1.43 - $2.2 $162,462 - $249,942	-113,610 Reduced 26.45%	315,853 $625,000
Q1 2022 May 16, 2022	SELL	$1.28 - $1.83 $166,992 - $238,747	-130,463 Reduced 23.3%	429,463 $786,000
Q4 2021 Feb 14, 2022	BUY	$1.09 - $1.66 $610,319 - $929,477	559,926 New	559,926 $789,000
Q2 2021 Aug 17, 2021	SELL	$1.51 - $2.07 $27,022 - $37,044	-17,896 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.67 - $2.95 $6,015 - $10,625	3,602 Added 25.2%	17,896 $31,000
Q4 2020 Feb 16, 2021	BUY	$1.8 - $2.56 $25,729 - $36,592	14,294 New	14,294 $28,000
Q4 2019 Feb 14, 2020	SELL	$3.89 - $5.15 $632,638 - $837,554	-162,632 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$3.19 - $5.39 $518,796 - $876,586	162,632 New	162,632 $724,000
Q2 2019 Aug 14, 2019	SELL	$3.52 - $5.24 $192,646 - $286,779	-54,729 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$2.61 - $4.35 $11,541 - $19,235	4,422 Added 8.79%	54,729 $207,000
Q4 2018 Feb 14, 2019	BUY	$2.17 - $6.12 $109,166 - $307,878	50,307 New	50,307 $120,000

Others Institutions Holding ADMA

# of Institutions

378

Shares Held

188M

Call Options Held

2.53M

Put Options Held

696K

View Full List

About ADMA BIOLOGICS, INC.

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.58B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

More about ADMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account